StreetAccount Summary - Trading higher/lower: EU mid-morning
Sartorius Stedim Biotech upgraded to outperform at Bernstein (timing uncertain) (€183.65, -7.70)
Sartorius Stedim Biotech proposes a dividend of €0.69/share (€213.10, -0.10)
Sartorius Stedim Biotech upgraded to hold from sell at Intron Health (€224.90, 0.00)
Powered by FactSet Research Systems Inc.